We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Safety Oversight Board -- 'Double Edged Sword' for Industry?
Drug Safety Oversight Board -- 'Double Edged Sword' for Industry?
June 23, 2006
The first year of the FDA’s Drug Safety Oversight Board (DSB) shows that the panel can help improve and accelerate drug reviews by providing a forum where senior officials can consult on drug safety issues, according to an agency official.